Skip to main content
. 2002 Oct 7;87(8):840–845. doi: 10.1038/sj.bjc.6600521

Figure 2.

Figure 2

CT scan of the liver depicting metastases prior to therapy (A) and the CR after 4 cycles of intravenous fotemustine in combination with subcutaneous IL-2 and IFNα (B).